Members of BERENICE consortium about Chagas' disease, led by Dr. Israel Molina, Director of the PROSICS (International Health Program of the Catalan Health Institute), had their Third General Assembly on the 28th January 2015.
The main objective of the meeting was to discuss with its 8 European and Latin American partners the progress of the project, which began on 1st September 2012, for a period of 5 years and which is currently in its 29th month of execution.


During the meeting, the Partners shared updates on project progress to date and discussed on how to move forward both at Work Package and Consortium levels.

The project is in a key moment to decide the final formulation to conduct Clinical Trials in humans, designed as an international multicenter Clinical Trial and which will take place in the facilities of the Hospital Vall Hebron and other sites such as Argentina, Bolivia or Mexico.